I spent my university years working part time dispensing meds in a community pharmacy.
"Would you like a cheaper generic brand if available" was pushed on practically every prescription brought in ... Because generics were higher margin for the pharmacy than brand name.
Doctors have been specifing "No generic substitution" for at least, over a decade.
Purely in my opinion, doctors blocking generic substitution if far more appropriate than pharmacies pushing biosimilars at consumers.
- Forums
- ASX - By Stock
- PAR
- Chart
Chart, page-2366
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 43479 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 0.220 |
12 | 212910 | 0.215 |
14 | 245866 | 0.210 |
8 | 182478 | 0.205 |
30 | 784855 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 43479 | 1 |
0.230 | 84999 | 2 |
0.235 | 26540 | 1 |
0.240 | 103500 | 4 |
0.250 | 109857 | 5 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online